RecruitingNCT05235867

Secretin in Refeeding

Secretin Levels in Refeeding-induced Polyuria (Cross Section)


Sponsor

University of California, Los Angeles

Enrollment

10 participants

Start Date

Feb 1, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

Patients with restrictive-type anorexia nervosa who are admitted to the hospital for feeding often urinate excessive amounts. Others have changes in the way that they handle acid and base. These issues prolong hospitalizations. Current data suggest that one hormone--named secretin--may control both urine output and how the body handles acid and base. This study will evaluate whether secretin levels are different in anorexic patients who urinate an excessive amount compared to those who urinate normal amounts. For this study, patients will have one extra blood draw before and after one meal during their hospitalization. The blood draw before the meal coincides with a standard of care blood draw. Also after the meal, subjects will be asked to provide one extra urine sample. Information from subject's medical records will also be used.


Eligibility

Min Age: 13 YearsMax Age: 24 Years

Inclusion Criteria12

  • Group 1:
  • male and female patients
  • age 13-24 years
  • diagnosis of restrictive-type anorexia nervosa
  • hospitalization for nutritional support
  • >4 cc/kg/day of urine output (a.k.a. "fluid dumpers"; n=5)
  • Group 2:
  • male and female patients
  • age 13-24 years
  • diagnosis of restrictive-type anorexia nervosa
  • hospitalization for nutritional support
  • <2 cc/kg/d of urine output (a.k.a. "non-dumpers"; n=5)

Exclusion Criteria7

  • hold
  • Anti-depressant, anti-psychotic, or anticonvulsant medications
  • Previous hospitalization within the past 6 months
  • Underlying metabolic disorder not related to anorexia nervosa (including chronic kidney disease, renal tubular disorders, and underlying endocrine disorders)
  • Pregnancy
  • NG or G-tube feeds after day 2 of hospitalization
  • > 10% of nutritional needs from supplemental feeds

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

University of California, Los Angeles (UCLA)

Los Angeles, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05235867


Related Trials